SUSAN WOLGAMOTT: Open Payments
NPI 1760894638 · BLOOMFIELD TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,915 in 177 payments from 17 companies in 2025. Trend: 2023 $110,564 · 2024 $88,965 · 2025 $57,915
Speaker / faculty: $45,022Travel & lodging: $7,495Food & beverage: $4,014Consulting: $1,300Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 44 | $17,563 |
| EVOKE PHARMA, INC. | 15 | $13,994 |
| ABBVIE INC. | 41 | $12,255 |
| Madrigal Pharmaceuticals | 31 | $11,506 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $1,829 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $269 |
| GENZYME CORPORATION | 4 | $95 |
| Ardelyx, Inc. | 5 | $90 |
| Exact Sciences Corporation | 1 | $79 |
| Gilead Sciences, Inc. | 3 | $46 |
Products named: TREMFYA, GIMOTI, REZDIFFRA, RINVOQ, SKYRIZI, TRULANCE, STELARA, ENTYVIO.
Industry payments across MI — which companies pay providers there.
